The link between increased level of IDO in AML cells and poor prognosis of patients with AML was presented also in other works [114,115,116,117], and this suggests that IDO inhibitors might facilitate therapy of AML through increasing anti-tumor immunity. This evidence concerns the gene IDO1 and neoplasm.